Delivery Order SPE2DB25D3201-SPE2DB25FNVSS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units) under a firm fixed price contract type. This competitive award, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for Welireg 40 mg tablets (90-count packages) with a ceiling value of $17,968.39. This firm fixed-price, non-set-aside contract is scheduled for completion by August 18, 2025, and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price contract is for the supply of WELIREG 40 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $17,968.39 and a completion date of January 6, 2025. It is a delivery order contract for the supply of WELIREG 40 MG TABLET 90S, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed price delivery order is for the supply of WELIREG 40 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,936.78, is for the delivery of WELIREG 40 MG TABLET 90S. The award has an ultimate completion date of July 8, 2025. Amerisourcebergen Drug Corp is the prime contractor for this delivery order. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WELIREG 40 MG TABLET 90S. The contract has a ceiling value of $17,968.39 and an ultimate completion date of July 3, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $34,736.28 and is for the supply of the prescription medication WELIREG 40 MG TABLET 90S. The delivery order is a firm fixed price contract with an ultimate completion date of October 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WELIREG 40 MG TABLET 90S. The firm-fixed-price contract has a ceiling value of $17,968.39 and an ultimate completion date of June 18, 2025. The award is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides a comprehensive global...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $40,759.20 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price contract, which is not set-aside, represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVSSDelivery Order
The Defense Logistics Agency awarded a $35,936.78 delivery order to AmerisourceBergen Drug Corp for 90-tablet supplies of Welireg 40 mg, a pharmaceutical product, with performance in Conshohocken, Pennsylvania and completion targeted for September 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order executes under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts and demonstrates capability to fulfill federal supply requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.9k | 8/15/25 |